Risikofaktorer for blødende magesår

Tidsskrift for den Norske Laegeforening

Volumn 130, Issue 11, 2010, Pages 1135-1139

  Søberg, Taran ^a,c   Hofstad, Bjørn ^a   Sandvik, Leiv ^a   Johansen, Maren ^a,d   Lygren, Idar ^b  

^a Gastromedisinsk avdeling ^*  (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c Medisinsk Avdeling   (Norway)

^d Pronova BioPharma Norge AS   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG COMBINATION; DUODENUM ULCER; FEMALE; HELICOBACTER INFECTION; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; PEPTIC ULCER BLEEDING; PROSPECTIVE STUDY; RISK FACTOR; STOMACH ULCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; RISK FACTORS; STOMACH ULCER; YOUNG ADULT;

EID: 77953699938     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.08.0693     Document Type: Article

References (33)

1. Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol 1998; 93: 2037-46.
2. Van Leerdam ME, Tytgat GN. Helicobacter pylori infection in peptic ulcer haemorrhage. Aliment Pharmacol Ther 2002; 16 (suppl 1): 66-78.
3. Rockall TA, Logan RF, Devlin HB et al. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 1995; 311: 222-6.
4. Bombardier C, Laine L, Reicin A et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000; 343: 1520-8.
5. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: metaanalysis. BMJ 2000; 321: 1183-7.
6. Hernandez-Diaz S, Rodriguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000; 160: 2093-9.
7. Langman MJ, Jensen DM, Watson DJ et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA 1999; 282: 1929-33.
8. Silverstein FE, Faich G, Goldstein JL et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000; 284: 1247-55.
9. Graumlich JF. Preventing gastrointestinal complications of NSAIDs. Risk factors, recent advances, and latest strategies. Postgrad Med 2001; 109: 117-8.
10. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus asprin in patients at risk of ischemic events (CAPRIE). Lancet 1996; 348: 1329-39.
11. de Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 1999; 319: 1106-9.
12. Johnsen SP, Sørensen HT, Mellemkjær L et al. Hospitalisation for upper gastrointestinal bleeding associated with use of oral anticoagulants. Thromb Haemost 2001; 86: 563-8.
13. Garcia Rodriguez LA, Hernandez-Diaz S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology 2001; 12: 570-6.
14. Nielsen GL, Sørensen HT, Mellemkjær L et al. Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study. Am J Med 2001; 111: 541-5.
15. Hylek EM, Heiman H, Skates SJ et al. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 1998; 279: 657-62.
16. Nasjonalt folkehelseinstitutt. Legemiddelforbruket i Norge. www.legemiddelforbruk.no (1.4.2008).
17. Pounder RND. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 21995; 9 (suppl 2): 33-9.
18. Chiorean MV, Locke GR, Zinsmeister AR et al. Changing rates of Helicobacter pylori testing and treatment in patients with peptic ulcer disease. Am J Gastroenterol 2002; 97: 3015-22.
19. Søberg T, Hofstad B, Lygren I. Medication in patients with upper gastrointestinal bleeding. Abstrakt. Scand J Gastroenterol 2004; 39 (suppl 240): 48.
20. Nasjonalt folkehelseinstitutt. Nasjonalt reseptbasert legemiddelregister. www.reseptregisteret.no (30.4.2008).
21. Nathan JP, Castellanos JT, Rosenberg JM et al. Impact of aspirin on the gastrointestinal-sparing effects of cyclooxygenase-2 inhibitors. Am J Health Syst Pharm 2003; 60: 392-4.
22. Laine L. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs - nice or necessary? Rev Gastroenterol Disord 2004; 4 (suppl 4): 33-41.
23. Bhatt DL, Scheiman J, Abraham NS et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2008; 52: 1502-17.
24. Garcia Rodriguez LA, Hernandez-Diaz S, de Abajo FJ. Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. Br J Clin Pharmacol 2001; 52: 563-71.
25. Garcia Rodriguez LA, Hernandez-Diaz S. Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Am J Epidemiol 2004; 159: 23-31.
26. Laine L. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors. Semin Arthritis Rheum 2002; 32 (suppl 1): 25-32.
27. Juurlink DN, Gomes T, Ko DT et al. A populationbased study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009; 180: 713-8.
28. Sharma S. Upper gastrointestinal bleeding after hip and knee arthroplasty. Orthopedics 2006; 29: 255-7.
29. Hernandez-Diaz S, Rodriguez LA. Steroids and risk of upper gastrointestinal complications. Am J Epidemiol 2001; 153: 1089-93.
30. Dalton SO, Johansen C, Mellemkjaer L et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 2003; 163: 59-64.
31. Lanas A, Garcia-Rodriguez LA, Arroyo MT et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 2006; 55: 1731-8.
32. Nordenstedt H, Nilson M, Johnsen R et al. Helicobacter pylori infection and gastrointestinal reflux in a population-based study (the HUNT study). Helicobacter 2007; 12: 16-22.
33. Asfeldt AM, Straume B, Erikson Steigen S et al. Changes in the prevalence of dyspepsia and Helicobacter pylori infection after 17 years: the Sørreisa gastrointestinal disorder study. Eur J Epidemiol 2008; 23: 625-33.